Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

BIZARRE: 28 - What They Never Told You

RFK Jr orders mifepristone review as anti-abortion groups push for ban

Health secretary cites ‘new data’ that emerged from flawed study conservatives are using to pressure US government

The Guardian - US · May 14, 2025

European court delivers blow to EU Commission over Von der Leyen-Pfizer texts

The European Court of Justice has upheld a transparency challenge over undisclosed text messages between EU Commission President Ursula von der Leyen and Pfizer’s CEO during the Covid-19 vaccine negotiations.

Radio France Internationale · May 14, 2025

Von der Leyen’s texts with Pfizer boss can be shared, says EU’s highest court

European court of justice says no ‘plausible explanation’ given for denying New York Times access to texts from pandemic

The Guardian - UK · May 14, 2025

From analysis to the latest developments in health,
read the most diverse news in one place.

RFK Jr. Admitting Big Pharma Paid Trump '$100 Million' Leaves Internet Stunned: 'Was That a Fraudian Slip?'

RFK Jr. told Americans President Trump cannot be bought while also revealing Trump accepted $100 million from Big Pharma.

Latin Times · May 13, 2025

Europe's Biggest 'Green' Methanol Plant Opens In Denmark

Europe's largest "green" methanol plant opened in Denmark on Tuesday, boosting the continent's emissions reduction efforts -- with customers ranging from shipping giant Maersk to toymaker Lego and pharmaceutical firm Novo Nordisk.

International Business Times · May 13, 2025

Nationwide eye care product recall as experts warn to stop using this product immediately

More than 1.8 million units of this eye care solution have been recalled

Evening Standard · May 13, 2025

Trump signs order aiming to slash US drug prices to match those abroad

Health policy experts support the ‘most favored nation’ plan but doubt it will withstand likely legal challenges

The Guardian - US · May 12, 2025

Read news from The Economist, FT, and more,
with one subscription

This serum is best-selling for a reason—it tackles everything from dryness to pigmentation, and costs less than £40

The ingredients lineup is impressive

Marie Claire · May 12, 2025

The Best Health Care Stocks to Buy

The best health care stocks offer investors a defensive hedge in an uncertain market. Here's how to find them.

Kiplinger · May 8, 2025

Americans would suffer most if Trump imposes pharma tariffs, sector warns

Industry says levies would hit supply chains, making medicines potentially unaffordable for some US patients

The Guardian - UK · May 5, 2025

Snake collector’s immunity quest opens path towards universal antivenom

Blood from man bitten hundreds of times by deadly snakes is used to create most broadly protective antivenom yet

The Guardian - UK · May 2, 2025

Trump hints at tariff reprieve for pharma companies that bring operations back to US

He suggests drugmakers would get ‘a lot of time’ to repatriate manufacturing before facing levies

The Guardian - UK · May 1, 2025

Doctors Pushed HIV Meds On Patients in Exchange For Lavish Meals, Trips, and Cash: Prosecutors

A pharmaceutical company that paid doctors kickbacks to push their HIV/AIDS drugs has agreed to pay a fine of more than $200 million.

Medical Daily · Apr 30, 2025

You might soon be able to get Wegovy from an online shop — here is where you need to visit

The move comes as Danish drugmaker Novo Nordisk has acted to slash the popular weight loss drug’s price

The Independent UK · Apr 29, 2025

Get all your
news in one place.

100's of premium titles.
One news app.

International Business Times · Apr 29, 2025

AstraZeneca Moves Some Production To US Amid Tariff Threat

British pharmaceutical giant AstraZeneca announced Tuesday that it has begun moving some of its European production to the United States, ahead of President Donald Trump's possible tariffs on the sector.

The Guardian - UK · Apr 29, 2025

Drugmaker AstraZeneca shifts more production to US amid Trump tariffs

UK and rest of Europe risk losing out to US and China unless they ramp up spending on new medicines, says CEO Pascal Soriot

International Business Times · Apr 25, 2025

Bayer Says Legal Woes Could Force It To Pull Weedkiller

German chemicals giant Bayer said Friday it could be forced to pull its Roundup weedkiller from the market if it is not able to contain simmering legal troubles.

The Guardian - UK · Apr 24, 2025

US drug firm Merck says existing Trump tariffs will cost it $200m this year

Company’s forecast does not account for threatened ‘major’ tariff that could also be levied on pharmaceutical imports

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK · Apr 22, 2025

Swiss drugmaker Roche to invest $50bn in US in effort to dodge Trump tariffs

Company says it will create 12,000 jobs in manufacturing and R&D over next five years

The Independent UK · Apr 20, 2025

More pharmacies offer to speed prescription deliveries to customers

America’s two largest retailers want to deliver prescriptions to your doorstep, sometimes in a matter of hours

The Guardian - UK · Apr 17, 2025

Ministers in ‘active conversation’ with UK drug firms over potential tariffs

Government seeks ways to shield industry from possible US levies amid concern over effect on medicine supply

International Business Times · Apr 16, 2025

Leadership Through Kelli Rodriguez's Lens: Diversity, Communication, & Women's Empowerment

For more than 20 years, Rodriguez has played an instrumental role in launching, restructuring, and scaling global and domestic brands, cementing her reputation as an industry leader.

International Business Times · Apr 11, 2025

Trump Tariffs Unnerve Locals In Irish 'Pharma' Hub

Vast pharmaceutical factories pepper the green landscape in southern Ireland, but the wind turbines next to the plants outside Cork are in the eye of Donald Trump's global trade storm.

Latin Times · Apr 11, 2025

Novartis Plans $23 Billion US Buildout as Pharma Faces Pressure From Trump

Novartis plans a $23 billion U.S. expansion to boost drug production and counter potential import tariffs.

International Business Times · Apr 9, 2025

Hedge Fund Managers Are Aggressively Buying Biotech Stocks Despite Trump Hinting at Pharma Tariffs

While Donald Trump spared pharma companies from his tariff announcement last week, he revealed yesterday plans to announce tariffs on the industry soon.

1 … 27 28 29 30

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.